Earticle

현재 위치 Home

포스터

Cerebrospinal fluid liquid biopsies for Mucopolysaccharidosis: absolute quantitation of glycans with high sensitivity using HILIC/MRM-MS

첫 페이지 보기
  • 발행기관
    한국당과학회 바로가기
  • 간행물
    한국당과학회 학술대회 바로가기
  • 통권
    2022 한국당과학회 연례학술대회 (2022.07)바로가기
  • 페이지
    pp.79-79
  • 저자
    Heejin Jeong, Myung Jin Oh, Nari Seo, Hyun Joo An
  • 언어
    영어(ENG)
  • URL
    https://www.earticle.net/Article/A415484

※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

원문정보

초록

영어
In recent years, liquid biopsy has been noted for its outstanding advantages over tissue biopsy including ease of sampling, effective monitoring, and longitudinal assessment of treatment dynamics. In particular, Cerebrospinal fluid(CSF), a body fluid that directly interacts with the extracellular fluid of the brain and central nervous system, is a representative body fluid used for liquid biopsy and is becoming a potential source for neurological study. Mucopolysaccharidosis is a fatal neurodegenerative lysosomal storage disease caused by lysosomal β-gal deficiency and of galactose-containing substrates accumulate in various tissues such as brain and liver. Therefore, continuous monitoring of changes in the expression of galactose substrates in the brain is important for the diagnosis and treatment of disease. However, the low protein content of the biofluid makes this difficult. Here, we developed a highly sensitive, absolute quantitation platform for N-glycans containing terminal galactose(A2G2/A2G2F) to determine mucopolysaccharidosis using liquid biopsy of mouse CSF within 2hours. N-glycans labeled with InstantPC were quantified using hydrophilic interaction chromatography(HILIC) coupled with multiple response monitoring(MRM)-MS. In particular, A2G2/A2G2F glycans are present in less than 5% even in very small amount of mouse CSF, but it is possible to quantify glycans in 300nL mouse CSF at the femtomole level. Indeed, we were able to achieve high reproducibility within 15% of CV in experimental/instrumental replicates in the concentration range of 0.1 to 500pg/μL with quantitative linearity. Our glycan quantification platform can be potentially applied for diagnosis and monitoring of patients for neurodegenerative diseases at trace amounts of CSF (about 5μL) in a much more convenient and non-invasive manner.

저자

  • Heejin Jeong [ Graduate School of Analytical Science and Technology, Chungnam National University, Asia-Pacific Glycomics Reference Site, Daejeon, 34134, Korea ]
  • Myung Jin Oh [ Graduate School of Analytical Science and Technology, Chungnam National University, Asia-Pacific Glycomics Reference Site, Daejeon, 34134, Korea ]
  • Nari Seo [ Graduate School of Analytical Science and Technology, Chungnam National University, Asia-Pacific Glycomics Reference Site, Daejeon, 34134, Korea ]
  • Hyun Joo An [ Graduate School of Analytical Science and Technology, Chungnam National University, Asia-Pacific Glycomics Reference Site, Daejeon, 34134, Korea ] Corresponding Author

참고문헌

자료제공 : 네이버학술정보

간행물 정보

발행기관

  • 발행기관명
    한국당과학회 [Korean Society for Glycoscience]
  • 설립연도
    2006
  • 분야
    의약학>약학
  • 소개
    본 학회는 화학, 생화학, 분자생물학, 미생물학, 식품공학, 의학, 약학, 유전공학 및 생물공학, 환경 및 기타 공업 등 전 분야의 탄수화물관련 이론과 기술을 연구 발전시키고 산학협동을 통해 이를 보급하여 국내 관련 산업의 발전 및 국민생활의 과학화에 기여하고자 하며, 이러한 목표와 비젼의 실현을 위해 회원들이 적극적인 참여와 활동을 전개하고자 한다.

간행물

  • 간행물명
    한국당과학회 학술대회
  • 간기
    연간
  • 수록기간
    2006~2022
  • 십진분류
    KDC 517 DDC 614

이 권호 내 다른 논문 / 한국당과학회 학술대회 2022 한국당과학회 연례학술대회

    피인용수 : 0(자료제공 : 네이버학술정보)

    함께 이용한 논문 이 논문을 다운로드한 분들이 이용한 다른 논문입니다.

      페이지 저장